Phase I study of CMV specific CTL for treatment of refractory CMV infection after allogeneic hematopoietic stem cell transplantatio
Phase 1
- Conditions
- Refractory CMV infection after allogeneic hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000001749
- Lead Sponsor
- Department of Pediatrics, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe or uncontrollable bacterial, fungal, and viral (except CMV) infection 2. Uncontrollable acute and chronic GVHD 3. Psychoses 4. History of allergic reaction to albumin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events
- Secondary Outcome Measures
Name Time Method Monitoring of CMV reactivation (quantitative PCR and CMV antigenemia) and CMV specific CTL in peripheral blood